◆ 会议时间:2025年9月6-9日 ◆ 会议简介: 2025年IASLC世界肺癌大会(WCLC2025)将于2025年9月6-9日在西班牙巴塞罗那举行,会议由国际肺癌研究协会(IASLC)主办。IASLC世界肺癌大会(WCLC)是世界上最大的致力于肺癌和其他胸部恶性肿瘤的多学科肿瘤学会议,每届都有来自全球100多个国家的7,000多名专业人士参会,共同探讨肺癌和其他胸部恶性肿瘤的最前沿治疗进展。 参会者包括外科医生、医学肿瘤学家、放射肿瘤学家、肺部学家、放射科医生、病理学家、流行病学家、基础研究科学家、护士和相关的卫生专业人员与患者代表。 国际肺癌研究协会(IASLC)是唯一致力于研究和根治肺癌和其他胸部恶性肿瘤的全球性组织,自1974年成立以来,其会员人数已增长到8,000多名,由来自各个学科和100多个国家/地区的肺癌和胸部肿瘤专家组成。IASLC在肺癌的病因学、流行病学、预防、诊断、治疗以及所有与肺癌相关的领域开展深入研究;通过主办全球会议、资助前沿研究、为IASLC成员、医学界和公众宣提供关于肺癌和其他胸部恶性肿瘤的教育和信息,致力于减轻肺癌对患者、家庭和社会的负担。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com). IASLC 2025 World Conference on Lung Cancer (WCLC2025) 时间/Date: 地点/Venue: 组织/Organized by:
The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research.
WCLC2025 摘要征文投稿: January 31, 2025 April 4, 2025 (23:59 PDT) April 4, 2025 (23:59 PDT) May 28, 2025 May 28, 2025 July 11, 2025 (23:59 PDT) July 30, 2025 (23:59 PDT) August 6, 2025 August 13, 2025 (10:00 PDT)
以下为往届会议信息,仅供参考! IASLC 2024 World Conference on Lung Cancer (WCLC2024) 时间/Date: 地点/Venue: 组织/Organized by: The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research.
Why attend WCLC 2024? World’s Largest Connect & Collaborate Exemplary Education Extensive Resources
摘要征文投稿: WCLC 2024 CALL FOR ABSTRACTS January 31, 2024 April 5, 2024 (23:59 PDT) April 5, 2024 (23:59 PDT) May 29, 2024 May 29, 2024 June 14, 2024 (23:59 PDT) July 10, 2024 (23:59 PDT) July 12, 2024 (23:59 PDT) July 23, 2024 (10:00 PDT) August 14, 2024 (10:00 PDT) Abstract Submission GuidelinesTo foster high-quality oral and written presentations at IASLC conferences, an implementation team will conduct a review of abstract titles and provide suggestions based on the IASLC Language Guide. We encourage you to review the Guide prior to submitting your abstract, to minimize later suggestions or edits and to help facilitate mutually respectful communication.
ABSTRACT TYPES ACCEPTED:REGULAR ABSTRACTDefinition: Original scientific research that summarizes work done and major research findings. Required sections for abstract submission:
CLINICAL TRIALS IN PROGRESS(eligible for designation as poster or e-poster only) Definition: Ongoing trials that have not reached pre-specified endpoints for analysis. Required sections:
Optional sections:
CASE SERIES(eligible for designation as poster or e-poster only) Definition: Detailed report of symptoms, signs, diagnosis, treatment and follow up of an individual patient. Must include a minimum of three (3), but preferably five (5) cases. Required sections for abstract submission:
LATE-BREAKING ABSTRACT (LBA) SUBMISSIONDefinition: LBA designation is not a means for extending the regular abstract deadline. Highly impactful studies that have complete data should be submitted as a regular abstract and will be considered for a prominent oral presentation based on scoring by the program committee. Any abstract that fails to meet LBA requirements will be designated as a regular abstract and rated based on the information available on the submission deadline. Submission requirements: Authors of LBA must submit a place holder abstract through the abstract portal by April 5, 2024 (23:59 PDT). Required sections for LBA place holder, which must be submitted by the April 5, 2024 deadline:
Required sections for final LBA, which must be submitted by June 14, 2024:
Review: The Scientific Program Committee will review LBA placeholder applications. Authors of approved LBAs will be notified and advised on deadlines and the processes for submitting final data by June 14, 2024. LBA abstracts not completed by this deadline will be automatically withdrawn and will not be considered for the meeting. The Scientific Program Committee will review the final LBA and notify the authors of its disposition by July 10, 2024.
WCLC2024 注册费: Early Registration Deadline: June 7, 2024 (23:59 PDT) IN-PERSON REGISTRATIONIASLC Member Fellows, Students Member* Registered Nurses, Allied Health Professionals Member* Developing Countries Member** Advocates Member* Non Member Fellows, Students Non-Member* Registered Nurses, Allied Health Professionals Non-Member* Developing Countries Non-Member** Advocates Non-Member* Patients / Survivors / Caregivers**
In-Person Registration Includes:
VIRTUAL REGISTRATIONIASLC Member Fellows, Students Member* Registered Nurses, Allied Health Professionals Member* Developing Countries Member** Advocates Member* Patients / Survivors / Caregivers** Non Member Fellows, Students Non-Member* Registered Nurses, Allied Health Professionals Non-Member* Developing Countries Non-Member** Advocates Non-Member*
Virtual Registration Includes:
*Proof of status needs to be provided during the online registration process. Please provide a student card or an official letter on your institution/organization’s letterhead which indicates proof of your status as a Student, Fellow, Trainee, Advocate, Registered Nurse, or Allied Health Professional. **Developing Countries: List of countries available at www.iaslc.org/Membership/Developing-Countries-List
Cancellation Policy Registration cancellations received in writing at the WCLC 2024 Conference Secretariat’s address on or before August 23, 2024, will be accepted and all fees refunded, less a 150 USD administrative fee, as per Committee policy. Cancellations received after August 23, 2024, will not be refunded; however, transfer of your registration to another person is permitted by re-accessing the original delegate’s registration via the confirmation letter and replacing with the new delegates information. No refunds will be made for non-attendance at the Conference. In the unlikely event that the Conference is cancelled, travel and accommodation costs will not be refunded.
2025年世界肺癌大会WCLC2025-IASLC世界肺癌大会-国际肺癌研究协会世界肺癌大会IASLC-WCLC |
© 版权声明
本文由分享者转载或发布,内容仅供学习和交流,版权归原文作者所有。如有侵权,请留言联系更正或删除。